This provides compelling evidence of a possible tumour suppressor role for LLGL2 in pre-metastatic epithelial ovarian cancer cells, corroborating the germline and somatic genomic data presented here to support it as a potentially novel HGSOC predisposition gene. The gene discussed is LLGL2; the disease is neoplasm.